LON:EKF EKF Diagnostics (EKF) Share Price, News & Analysis GBX 26.70 -0.30 (-1.11%) As of 12:07 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock About EKF Diagnostics Stock (LON:EKF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get EKF Diagnostics alerts:Sign Up Key Stats Today's Range 26.70▼ 27.5050-Day Range 23.37▼ 27.2452-Week Range 22▼ 32Volume124,782 shsAverage Volume371,747 shsMarket Capitalization£114.94 millionP/E Ratio56.81Dividend Yield4.65%Price TargetGBX 35Consensus RatingBuy Company Overview EKF is an AIM-listed global diagnostics business focussed on: ● Point-of-Care analysers in the key areas of Hematology and Diabetes ● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide. Read More EKF Diagnostics Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks37th Percentile Overall ScoreEKF MarketRank™: EKF Diagnostics scored higher than 37% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.7 / 5Analyst RatingBuy Consensus RatingEKF Diagnostics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and no sell ratings.Upside PotentialEKF Diagnostics has a consensus price target of GBX 35, representing about 31.1% upside from its current price of GBX 26.70.Amount of Analyst CoverageEKF Diagnostics has only been the subject of 1 research reports in the past 90 days.Read more about EKF Diagnostics' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of EKF Diagnostics is 56.81, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 42.78.Price to Earnings Ratio vs. SectorThe P/E ratio of EKF Diagnostics is 56.81, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 17.54.Price to Book Value per Share RatioEKF Diagnostics has a P/B Ratio of 1.73. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for EKF. Dividend1.7 / 5Dividend StrengthWeak Dividend LeadershipEKF Diagnostics is a leading dividend payer. It pays a dividend yield of 4.65%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthEKF Diagnostics does not have a long track record of dividend growth.Read more about EKF Diagnostics' dividend. News and Social Media0.0 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 3 news articles for EKF Diagnostics this week, compared to 0 articles on an average week. Company Ownership1.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, EKF Diagnostics insiders have not sold or bought any company stock.Percentage Held by Insiders39.73% of the stock of EKF Diagnostics is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions22.64% of the stock of EKF Diagnostics is held by institutions.Read more about EKF Diagnostics' insider trading history. Receive EKF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for EKF Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EKF Stock News HeadlinesEKF Diagnostics Reports Encouraging First Quarter and Maintains Full-Year Outlook (EKF)May 19 at 8:07 AM | uk.finance.yahoo.comEKF Diagnostics (LON:EKF) Stock Price Passes Above Two Hundred Day Moving Average - What's Next?May 16 at 3:39 AM | americanbankingnews.comSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a $1.75 trillion IPO - larger than Saudi Aramco and any tech offering in history. CNBC calls it 'the big market event of 2026.' According to former tech executive and angel investor Jeff Brown, there's a way to claim a stake before the public filing drops, starting with as little as $500.May 19 at 1:00 AM | Brownstone Research (Ad)EKF Diagnostics Holdings plc (EKDHF)May 14, 2026 | nasdaq.comEKF Diagnostics acquires technology assets from Sweden's Beep InsightsApril 13, 2026 | lse.co.ukPenarth firm EKF Diagnostics boosted with sport training tech acquisitionApril 13, 2026 | uk.news.yahoo.comEKF Diagnostics Holdings PLC EKFApril 10, 2026 | morningstar.comMEARNINGS: Michelmersh profit declines; EKF sales and profit push aheadMarch 24, 2026 | lse.co.ukSee More Headlines EKF Stock Analysis - Frequently Asked Questions How have EKF shares performed this year? EKF Diagnostics' stock was trading at GBX 26.10 at the beginning of 2026. Since then, EKF shares have increased by 2.3% and is now trading at GBX 26.70. How were EKF Diagnostics' earnings last quarter? EKF Diagnostics Holdings plc (LON:EKF) announced its quarterly earnings results on Tuesday, March, 24th. The company reported $0.47 EPS for the quarter. EKF Diagnostics had a net margin of 4.12% and a trailing twelve-month return on equity of 3.01%. How do I buy shares of EKF Diagnostics? Shares of EKF stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of EKF Diagnostics own? Based on aggregate information from My MarketBeat watchlists, some other companies that EKF Diagnostics investors own include ERBA Diagnostics (ERBA), boohoo group (BOO), Lloyds Banking Group (LLOY), 888 (888), Abcam (ABC), ASOS (ASC) and Babcock International Group (BAB). Company Calendar Last Earnings3/24/2026Today5/19/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolLON:EKF CIKN/A Webwww.ekfdiagnostics.com Phone+44-29-20710570FaxN/AEmployees356Year FoundedN/APrice Target and Rating Average Price Target for EKF DiagnosticsGBX 35 High Price TargetGBX 35 Low Price TargetGBX 35 Potential Upside/Downside+31.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Trailing Twelve Months)GBX 0.47 Trailing P/E Ratio56.81 Forward P/E Ratio11.61 P/E GrowthN/ANet Income£4.68 million Net Margins4.12% Pretax MarginN/A Return on Equity3.01% Return on Assets5.27% Debt Debt-to-Equity Ratio2.01 Current Ratio4.16 Quick Ratio1.77 Sales & Book Value Annual Sales£51.56 million Price / Sales2.23 Cash FlowGBX 2.51 per share Price / Cash Flow10.64 Book ValueGBX 15.41 per share Price / Book1.73Miscellaneous Outstanding Shares430,503,000Free FloatN/AMarket Cap£114.94 million OptionableNot Optionable Beta0.49 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (LON:EKF) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EKF Diagnostics Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share EKF Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
